Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v14-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2022-03-25 | 2020-10-29 |
| Drug Identification Number | 00885975 | 00885975 |
| Brand name | VIVOTIF | VIVOTIF |
| Common or Proper name | TYPHOID VACCINE LIVE ORAL ATTENUATED TY21A | TYPHOID VACCINE LIVE ORAL ATTENUATED TY21A |
| Company Name | BAVARIAN NORDIC AS | BAVARIAN NORDIC AS |
| Ingredients | TYPHOID VACCINE | TYPHOID VACCINE |
| Strength(s) | 10B | 10B |
| Dosage form(s) | CAPSULE (ENTERIC-COATED) | CAPSULE (ENTERIC-COATED) |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 4 enteric-coated capsules per blister | 4 enteric-coated capsules per blister |
| ATC code | J07AP | J07AP |
| ATC description | BACTERIAL VACCINES | BACTERIAL VACCINES |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-12-17 | |
| Actual start date | 2021-06-30 | |
| Estimated end date | 2022-03-22 | Unknown |
| Actual end date | 2022-03-24 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Emergent has made the difficult decision to temporarily discontinue product distribution due to significant reduction in demand and following an assessment of data from a wide range of sources including government institutions, external research firms, and industry expert reports that point to a lengthy recovery period for international travel due to the COVID-19 pandemic. We remain fully committed to travel health and seek to properly position ourselves for the return of global travel and our products to the market in the near future. Pending further notification, the last ship date for VIVOTIF® (Typhoid Vaccine Live Oral Ty21a) will be December 17, 2020. All product being shipped from today through the last ship date will have the expiration date January 2021. | |
| Health Canada comments |